AMLITELIMAB
UNII YZ6BH6TN8P

Substance Identification & Data

This profile provides standardized clinical and technical data for Amlitelimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YZ6BH6TN8P.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2378692-15-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

YZ6BH6TN8P

CAS Registry Number

2378692-15-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

AMLITELIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C179073

National Cancer Institute reference terminology for clinical and research data.

INN ID

11545

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-32

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Amlitelimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

AMLITELIMAB

Common Names & Synonyms

AMLITELIMAB [INN]

AMLITELIMAB [USAN]

AMLITELIMAB [WHO-DD]

IMMUNOGLOBULIN G4 (235-PROLINE,242-GLUTAMIC ACID), ANTI-(HUMAN OX40 LIGAND) (HUMAN MONOCLONAL KY1005-2D10 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL KY1005-2D10 .KAPPA.-CHAIN, DIMER